These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21671254)

  • 1. Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-β prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes.
    Maldonado H; Ramírez E; Utreras E; Pando ME; Kettlun AM; Chiong M; Kulkarni AB; Collados L; Puente J; Cartier L; Valenzuela MA
    J Neurosci Res; 2011 Sep; 89(9):1489-98. PubMed ID: 21671254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microtubule proteins and their post-translational forms in the cerebrospinal fluid of patients with paraparesis associated with HTLV-I infection and in SH-SY5Y cells: an in vitro model of HTLV-I-induced disease.
    Maldonado H; Ortiz-Riaño E; Krause B; Barriga A; Medina F; Pando ME; Alberti C; Kettlun AM; Collados L; García L; Cartier L; Valenzuela MA
    Biol Res; 2008; 41(3):239-59. PubMed ID: 19399337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing.
    Wen Y; Planel E; Herman M; Figueroa HY; Wang L; Liu L; Lau LF; Yu WH; Duff KE
    J Neurosci; 2008 Mar; 28(10):2624-32. PubMed ID: 18322105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.
    Plattner F; Angelo M; Giese KP
    J Biol Chem; 2006 Sep; 281(35):25457-65. PubMed ID: 16803897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidic acid induces neurite retraction in differentiated neuroblastoma cells via GSK-3β activation.
    Sun Y; Kim NH; Yang H; Kim SH; Huh SO
    Mol Cells; 2011 May; 31(5):483-9. PubMed ID: 21499833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways.
    Hu JP; Xie JW; Wang CY; Wang T; Wang X; Wang SL; Teng WP; Wang ZY
    Brain Res Bull; 2011 May; 85(3-4):194-200. PubMed ID: 21435383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tax and Semaphorin 4D Released from Lymphocytes Infected with Human Lymphotropic Virus Type 1 and Their Effect on Neurite Growth.
    Quintremil S; Alberti C; Rivera M; Medina F; Puente J; Cartier L; Ramírez E; Tanaka Y; Valenzuela MA
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):68-79. PubMed ID: 26389656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal exposure to lead (Pb) promotes Tau phosphorylation in the rat brain in a GSK-3β and CDK5 dependent manner: Relevance to neurological disorders.
    Gąssowska M; Baranowska-Bosiacka I; Moczydłowska J; Tarnowski M; Pilutin A; Gutowska I; Strużyńska L; Chlubek D; Adamczyk A
    Toxicology; 2016 Mar; 347-349():17-28. PubMed ID: 27012722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1-infected cells and its association with cyclin A/cdk2.
    de La Fuente C; Santiago F; Chong SY; Deng L; Mayhood T; Fu P; Stein D; Denny T; Coffman F; Azimi N; Mahieux R; Kashanchi F
    J Virol; 2000 Aug; 74(16):7270-83. PubMed ID: 10906181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tax posttranslational modifications and interaction with calreticulin in MT-2 cells and human peripheral blood mononuclear cells of human T cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
    Medina F; Quintremil S; Alberti C; Barriga A; Cartier L; Puente J; Ramírez E; Ferreira A; Tanaka Y; Valenzuela MA
    AIDS Res Hum Retroviruses; 2014 Apr; 30(4):370-9. PubMed ID: 24321043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine.
    Patrick C; Crews L; Desplats P; Dumaop W; Rockenstein E; Achim CL; Everall IP; Masliah E
    Am J Pathol; 2011 Apr; 178(4):1646-61. PubMed ID: 21435449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation.
    Jämsä A; Hasslund K; Cowburn RF; Bäckström A; Vasänge M
    Biochem Biophys Res Commun; 2004 Jul; 319(3):993-1000. PubMed ID: 15184080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
    Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
    J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons.
    Cho DH; Lee EJ; Kwon KJ; Shin CY; Song KH; Park JH; Jo I; Han SH
    J Neurochem; 2013 Sep; 126(5):685-95. PubMed ID: 23581463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta.
    Li T; Hawkes C; Qureshi HY; Kar S; Paudel HK
    Biochemistry; 2006 Mar; 45(10):3134-45. PubMed ID: 16519508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse.
    Planel E; Yasutake K; Fujita SC; Ishiguro K
    J Biol Chem; 2001 Sep; 276(36):34298-306. PubMed ID: 11441005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
    Ishii T; Furuoka H; Muroi Y; Nishimura M
    J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative resistance of Cdk5-phosphorylated CRMP2 to dephosphorylation.
    Cole AR; Soutar MP; Rembutsu M; van Aalten L; Hastie CJ; McLauchlan H; Peggie M; Balastik M; Lu KP; Sutherland C
    J Biol Chem; 2008 Jun; 283(26):18227-37. PubMed ID: 18460467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of tau aggregation by cdk5 and GSK3β.
    Lee S; Hall GF; Shea TB
    J Alzheimers Dis; 2011; 26(2):355-64. PubMed ID: 21677377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of endogenous beta-amyloid overproduction on tau phosphorylation in cell culture.
    Wang ZF; Li HL; Li XC; Zhang Q; Tian Q; Wang Q; Xu H; Wang JZ
    J Neurochem; 2006 Aug; 98(4):1167-75. PubMed ID: 16762022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.